Sunday, November 17, 2024
Latest:
- Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial
- Interview with director of GCP Alliance – Europe
- Experience of Computerizing Site Management Processes
- For the first time the President of ASCO gave a lecture to our oncologists
- Thoughts of ASCO President 2009-2010. Prof.D.Blayney.
